Charles Schwab Investment Management Inc. increased its holdings in Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 2.8% ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

Let’s dig into the relative performance of Vertex Pharmaceuticals (NASDAQ:VRTX) and its peers as we unravel the now-completed Q4 therapeutics earnings season. Over the next few years, therapeutic ...

Disc Medicine (NASDAQ:IRON – Get Free Report) is expected to be posting its quarterly earnings results before the market ...

East Grand Forks defenseman Cole Bies (2) and forward Cooper Hills (15) hold up the class 1A boy’s hockey championship trophy as they celebrate with their teammates after defeating St. Cloud ...

To offset that pressure, Altria consistently raises its prices, cuts costs, and buys back shares to boost its earnings per share (EPS) and dividends. Over the past five years, the company bought ...

Based on the popular Chinese novel titled 'Loving You is the Best Thing I Have Done', The Best Thing is an urban romantic-drama that follows the love story of a traditional Chinese medicine doctor ...

Reports FY24 revenue $2.983M vs $0 last year. “Entering 2025 marks the next chapter for Prime Medicine (PRME) as we look to share initial data for our most advanced product candidate ...

The company posted an earnings per share (EPS) of $0.54, falling short of the $0.58 forecasted by analysts. Revenue also missed expectations, coming in at $3.52 billion against a projected $3.62 ...